We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cholesterol Crystals Suggest Looming Heart Attack

By HospiMedica International staff writers
Posted on 28 Aug 2017
Cholesterol crystals that pierce the arterial plaque and intima trigger local and systemic inflammation that can lead to a myocardial infarction (MI), according to a new study.

Researchers at Michigan State University (MSU; East Lansing, USA) conducted a study involving 240 emergency room patients who died of MI in order to examine the role of cholesterol in the crystallized state on atherosclerosis and plaque rupture, and its contribution to acute MI and stroke. More...
To visualize the cholesterol crystals, the researchers processed the tissue without ethanol. They found that cholesterol expands when crystallizing from the liquid to the solid state, which is the presumed cause of plaque rupture by the sharp-tipped crystals growing out of the plaque’s necrotic core.

The researchers found that in patients who died of MI, culprit coronary lesions had extensive cholesterol crystals perforating the fibrous cap and intima, while atherosclerotic patients who died of other causes did not have such perforating crystals. They also found that cholesterol crystals traveling downstream from the plaque rupture site can scrape the endothelium and promote vasospasm, and that cholesterol crystals lodging into the muscle can trigger an inflammation with necrosis, independent of circulatory compromise or ischemia. The study was published on May 1, 2017, in Cardiovascular Innovations and Applications.

“In previous studies, we showed that when cholesterol goes from a liquid to a solid, or crystal state, it expands in volume like ice and water. This expansion inside the wall of the artery can tear it and block blood flow causing a heart attack or stroke,” said senior author George Abela, MD, chief cardiologist at MSU. “Since cholesterol crystals form very early in the process of heart disease, with great potential to aggravate atherosclerosis, we can target new therapies by reducing cholesterol crystal deposits early on or use an inhibitor to block the inflammatory biomarker.”

Cholesterol is a modified steroid in the form of a lipid molecule, biosynthesized by all animal cells, and is an essential structural component comprising up to 30% of all cell membranes. Cholesterol also serves as a precursor for the biosynthesis of steroid hormones, bile acid, and vitamin D.

Related Links:
Michigan State University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.